Skip to main content

Reporter

Hayman named to lead new Shared Clinical Services Division

Nov. 22, 2022—Vanderbilt's Jim Hayman, MS, MBA, has been named to the newly created role of Executive Vice President for the Shared Clinical Services Division.

Read more


Risk score for muscular dystrophy

Nov. 22, 2022—An imaging-based risk score can identify patients with Duchenne muscular dystrophy who are at greater risk of early mortality, allowing more intensive treatment and potentially prolonging life.

Read more


Lecture honors first executive director of the Meharry-Vanderbilt Alliance

Nov. 21, 2022—The Meharry-Vanderbilt Alliance recently sponsored the Clifton K. Meador MD Inaugural Lectureship with Christopher Lathan, MD, MS, MPH, chief clinical access and equity officer, Dana-Farber Cancer Institute, serving as keynote speaker.

Read more


Vanderbilt mourns loss of former Rheumatology director Thomas

Nov. 21, 2022—James Ward “Tom” Thomas II, MD, former director of Vanderbilt’s Division of Rheumatology and Immunology, died Nov. 16 following a battle with cancer. He was 74.

Read more


Suicide notes

Nov. 21, 2022—Natural language processing of notes in electronic health records can identify suicidal behavior and could be used to directly improve real-time risk prediction algorithms.

Read more


Improving awareness and understanding of antimicrobial resistance is crucial

Nov. 17, 2022—The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.

Read more


Surgery for hereditary breast cancer

Nov. 17, 2022—Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.

Read more


A marker for mortality

Nov. 17, 2022—A urine biomarker of inflammation was associated with increased mortality and multiple lifestyle factors, suggesting that modifications could help reduce premature mortality.

Read more


Grants spur efforts to create molecular ‘atlases’ of organs

Nov. 17, 2022—Vanderbilt researchers have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues.

Read more


VUMC adopts updated kidney function equation to better guide patient care decisions

Nov. 17, 2022—In December Vanderbilt University Medical Center will again update the equation used for estimating kidney function with the goals of improving health equity and better guiding patient care decisions.

Read more


Study supports removing race from estimate of kidney function

Nov. 17, 2022—An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.

Read more


Several from VUMC among most highly cited researchers

Nov. 17, 2022—Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more